Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

brain tumours

  • Open Access
    Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours
    DANIELLE BOLLER, KATHRIN T. DOEPFNER, ANGELA DE LAURENTIIS, ANA S. GUERREIRO, MARIN MARINOV, TAREK SHALABY, PAUL DEPLEDGE, ANTHONY ROBSON, NAHID SAGHIR, MASAHIKO HAYAKAWA, HIROYUKI KAIZAWA, TOMONOBU KOIZUMI, TAKAHIDE OHISHI, SARAH FATTET, OLIVIER DELATTRE, ANELIA SCHWERI-OLAC, KATRIN HÖLAND, MICHAEL A. GROTZER, KARL FREI, OLIVIER SPERTINI, MICHAEL D. WATERFIELD and ALEXANDRE ARCARO
    Anticancer Research June 2022, 42 (6) 3217-3230; DOI: https://doi.org/10.21873/anticanres.15812
  • You have access
    Concomitant Treatment of Malignant Brain Tumours With CBD – A Case Series and Review of the Literature
    RUDOLF LIKAR, MARKUS KOESTENBERGER, MARTIN STULTSCHNIG and GERHARD NAHLER
    Anticancer Research October 2019, 39 (10) 5797-5801; DOI: https://doi.org/10.21873/anticanres.13783
  • You have access
    No Evidence for Increased Brain Tumour Incidence in the Swedish National Cancer Register Between Years 1980-2012
    JONAS NILSSON, JACOB JÄRÅS, ROGER HENRIKSSON, GEORG HOLGERSSON, STEFAN BERGSTRÖM, JIMMY ESTENBERG, TORSTEN AUGUSTSSON and MICHAEL BERGQVIST
    Anticancer Research February 2019, 39 (2) 791-796; DOI: https://doi.org/10.21873/anticanres.13176
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire